DK169055B1 - Anvendelse af piperazinderivater til fremstilling af et farmaceutisk præparat til beskyttelse af hjerneceller - Google Patents

Anvendelse af piperazinderivater til fremstilling af et farmaceutisk præparat til beskyttelse af hjerneceller Download PDF

Info

Publication number
DK169055B1
DK169055B1 DK427887A DK427887A DK169055B1 DK 169055 B1 DK169055 B1 DK 169055B1 DK 427887 A DK427887 A DK 427887A DK 427887 A DK427887 A DK 427887A DK 169055 B1 DK169055 B1 DK 169055B1
Authority
DK
Denmark
Prior art keywords
group
ethanol
carbon atoms
diphenylmethylpiperazinyl
cells
Prior art date
Application number
DK427887A
Other languages
Danish (da)
English (en)
Other versions
DK427887D0 (da
DK427887A (da
Inventor
Kyuya Kogure
Mitsuo Masaki
Original Assignee
Nippon Chemiphar Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Chemiphar Co filed Critical Nippon Chemiphar Co
Publication of DK427887D0 publication Critical patent/DK427887D0/da
Publication of DK427887A publication Critical patent/DK427887A/da
Application granted granted Critical
Publication of DK169055B1 publication Critical patent/DK169055B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK427887A 1986-08-20 1987-08-17 Anvendelse af piperazinderivater til fremstilling af et farmaceutisk præparat til beskyttelse af hjerneceller DK169055B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP61194925A JPH08776B2 (ja) 1986-08-20 1986-08-20 脳細胞保護作用を有する医薬組成物
JP19492586 1986-08-20

Publications (3)

Publication Number Publication Date
DK427887D0 DK427887D0 (da) 1987-08-17
DK427887A DK427887A (da) 1988-02-21
DK169055B1 true DK169055B1 (da) 1994-08-08

Family

ID=16332624

Family Applications (1)

Application Number Title Priority Date Filing Date
DK427887A DK169055B1 (da) 1986-08-20 1987-08-17 Anvendelse af piperazinderivater til fremstilling af et farmaceutisk præparat til beskyttelse af hjerneceller

Country Status (7)

Country Link
US (1) US4835155A (ja)
EP (1) EP0256890B1 (ja)
JP (1) JPH08776B2 (ja)
KR (1) KR950009095B1 (ja)
AU (1) AU603373B2 (ja)
DE (1) DE3781483T2 (ja)
DK (1) DK169055B1 (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2614021B1 (fr) * 1987-04-14 1991-03-01 Andre Buzas Derives de la 1-((1,1-diphenyl)-1-alcenyl)-piperazine, procede d'obtention et compositions pharmaceutiques les contenant
JPH07121864B2 (ja) * 1987-06-26 1995-12-25 日本ケミファ株式会社 脳障害抑制作用を有する医薬組成物
TW199890B (ja) * 1988-05-23 1993-02-11 Glaxo Group Ltd
NZ232493A (en) * 1989-02-14 1992-06-25 Toyama Chemical Co Ltd Aryl- or heterocyclyl-substituted 1,2-ethanediol derivatives and pharmaceutical compositions
US5280032A (en) * 1989-02-14 1994-01-18 Toyama Chemical Co., Ltd. 1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same
JP2679872B2 (ja) * 1989-04-28 1997-11-19 明治製菓株式会社 Ｎ−置換ピペラジン誘導体を含む脳機能障害改善剤
EP0398720A3 (en) * 1989-05-18 1991-07-03 Glaxo Group Limited Piperazine derivatives
DE4108527A1 (de) * 1991-03-15 1992-09-17 Basf Ag Neue 1-(4-cyano-4-aryl-cyclohexyl)piperazine, ihre herstellung und verwendung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2820937A1 (de) * 1978-05-12 1979-11-15 Dolorgiet Arzneimittelfabrik Arzneimittel
EP0067897A1 (en) * 1981-06-22 1982-12-29 Tanabe Seiyaku Co., Ltd. A pharmaceutical composition for use in raised intracranial pressure
JPS58124776A (ja) * 1982-01-21 1983-07-25 Nippon Chemiphar Co Ltd 新規ピペラジン誘導体およびその製造法ならびにこれを含有する脳循環改善剤
JPS59101475A (ja) * 1982-12-02 1984-06-12 Nippon Chemiphar Co Ltd 新規ピペラジン誘導体およびその製造法ならびにこれを含有する脳循環改善剤
FR2588188B1 (fr) * 1985-10-04 1988-01-08 Delalande Sa Comprime de sel(s) hydrosoluble(s) de cinepazide a liberation programmee et son procede de preparation

Also Published As

Publication number Publication date
AU7720487A (en) 1988-02-25
DK427887D0 (da) 1987-08-17
US4835155A (en) 1989-05-30
AU603373B2 (en) 1990-11-15
EP0256890B1 (en) 1992-09-02
DK427887A (da) 1988-02-21
DE3781483T2 (de) 1993-04-22
JPH08776B2 (ja) 1996-01-10
EP0256890A3 (en) 1990-02-14
DE3781483D1 (de) 1992-10-08
JPS6351328A (ja) 1988-03-04
KR880002528A (ko) 1988-05-09
EP0256890A2 (en) 1988-02-24
KR950009095B1 (ko) 1995-08-14

Similar Documents

Publication Publication Date Title
RU2429237C2 (ru) N-(2-тиазолил)амидные производные в качестве ингибиторов gsk-3
CN108948002A (zh) 五元并六元氮杂芳环类化合物、其制备方法、药用组合物及其应用
JP2023182589A (ja) フェニルスルホンアミドを含む薬学的組成物、及びそれらの治療的適用
DK169055B1 (da) Anvendelse af piperazinderivater til fremstilling af et farmaceutisk præparat til beskyttelse af hjerneceller
HU185523B (en) Method for producing a phenyl-alkyl-aminoethyl-salicylamide
WO2018135449A1 (ja) 抗重症熱性血小板減少症候群ウイルス薬
US4560686A (en) Method for treating circulatory diseases by using (2-lower alkoxyphenyl)piperazine derivatives
EP1699778B1 (fr) Derives de (4-phenylpiperazin-1-yl)acylpiperidine, leur preparation et leur application en therapeutique
SK2722002A3 (en) Use of bis-sulfonamides for producing medicaments used for preventing or treating hyperlipidaemia
US20030171379A1 (en) Methods of treating, preventing, or inhibiting inflammation with Mactanamide compounds
HU199858B (en) Process for producing piperazinecarboxylic acid derivatives and pharmaceutical compositions comprising such compound
JP5752239B2 (ja) 尿素化合物及びアポトーシスを阻害するためのその使用
CN113214097B (zh) 治疗阿尔茨海默病的化合物
CN113425720A (zh) 亚胺糖化合物在制备抗SARS-CoV-2病毒的药物中的用途
CN105130960B (zh) 1,3,5-三嗪类衍生物及其应用
JP2006347942A (ja) βアミロイド生成抑制剤
CN108558810B (zh) 具有rock激酶抑制作用的黄酮类衍生物
JPS588385B2 (ja) コウウツビヨウカツセイオユウスル カゴウブツノセイゾウホウ
US20240018129A1 (en) Compounds as pu. 1 inhibitors
JPH10245336A (ja) Ｎａ／Ｃａ交換系阻害剤
US5968955A (en) Disubstituted piperidine derivatives as neuroprotective agents
BRPI0903803A2 (pt) composto, isÈmero do composto, processo de sua preparação, composto intermediário, composição farmacêutica; medicamento, uso dos compostos e método de tratamento
JP3681770B2 (ja) 老年性痴呆症又はアルツハイマー病治療剤
JP3388775B2 (ja) 脳障害改善剤
JPH07118262A (ja) 新規１，２−ジチオール−３−チオン誘導体

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed